Patient-First Experience

Good Samaritan Medical Center continues to invest and redefine the standards in cancer care. Our approach brings together a multidisciplinary team of cancer specialists and allied health professionals, advanced technology and cancer resources.

With a reimagined experience, The Norma E. & Miles M. Zission Comprehensive Breast Center of the Palm Beaches greets patients with a modern aesthetic bolstered with innovative technologies and all designed within a calming, peaceful atmosphere.

Here, patients and their families receive comprehensive diagnosis and support services, with the compassion that has been a tradition at Good Samaritan for more than 100 years.

Nationally Accredited

The Breast Center is designated by the American College of Surgeons as a National Accreditation Program for Breast Centers (NAPBC), a designation reserved for breast centers that achieve high standards across the most effective breast cancer treatments. The Breast Center is also a Breast Imaging Center of Excellence by the American College of Radiology.

A Continuum of Care

Nurse Navigation Program

The Nurse Navigator’s mission is to help guide patients with a breast cancer diagnosis through their journey. The Nurse Navigator meets each patient at their point of need and can help provide education, resource referral, advocacy, support and guidance. The Nurse Navigator collaborates with the entire multidisciplinary team to facilitate informed and coordinated care from a first visit through diagnosis, treatment and survivorship. To reach our Nurse Navigator, please call 561.671.7150.

Lymphedema Therapy

As part of the full-service treatment offered at the Breast Center, a certified lymphedema therapist is located onsite for the treatment of lymphedema. Lymphedema is chronic swelling in a portion of the body which can occur days, months, or years after cancer treatment. The lymphedema therapist is specially trained to treat patients with lymphedema and provides hand-on therapy to help minimize risk of poor mobility, infection, pain and deformity.

Cancer Genetic Testing

By investigating the patient’s family medical history and undergoing testing to identify gene mutations, we can help determine their risk for certain types of cancer. Before and after genetic testing, we provide counseling sessions, during which we will help the patient understand the complex results and outcomes so they can make informed decisions.

Our Technologists

From our patient navigators who are registered nurses available to answer hospital-related questions, to our fellowship-trained radiologist and fellowship-trained breast surgeon, to our imaging techs, our compassionate team of experienced physicians and staff is focused on providing comprehensive breast care with an emphasis on prevention, early detection and personalized treatment.

Early Detection Technology

The Genius 3D Mammography Exam with Hologic Clarity HD

Helps to identify cancer earlier with sharper and expedited images; and reduces follow-up appointments by up to 40%.

Affirm Breast Biopsy Guidance System

Empowers doctors to quickly perform 3D breast biopsies and accurately target regions of interest for precision detection methods.

Supersonic Mach 40 Ultrasound

Captures highest resolution images of patients to enhance diagnostic certainty, regardless of tissue density.

Contrast Enhanced Mammography (CEM)

Contrast-enhanced mammography (CEM) is a breast imaging technique that uses an iodine-based intravenous (IV) contrast agent in combination with a standard digital mammogram. Some cancers that are not visible on standard mammograms or tomosynthesis can be seen with the addition of contrast. The iodine-based contrast agent used is the same as the contrast agent used for CT scans, but different from the gadolinium-based contrast agents used in MRI. CEM can be used to assess the extent of cancer in women with newly diagnosed breast cancer and to monitor response to chemotherapy given prior to surgery. CEM can be used to evaluate breast symptoms or abnormalities seen on mammograms. In women recommended for screening MRI, but who are unable to tolerate or access MRI, CEM can be performed as an alternative test ^{[1, 2].} Screening with CEM is an area of active investigation and is currently considered an “off-label use” by the United States Food and Drug Administration (FDA).

Monticciolo DL, Newell MS, Moy L, Lee CS, Destounis SV. Breast Cancer Screening for Women at Higher-than- Average Risk: Updated Recommendations from the ACR. J Am Coll Radiol 2023;20:902-914.

National Comprehensive Cancer Network. NCCN Guidelines. Breast cancer screening and diagnosis v.3.2023. Available at: https://www.nccn.org/professionals/ physician_gls/pdf/breast- screening.pdf. Accessed January 23, 2024.